Drug Type Small molecule drug |
Synonyms 10,11-dihydro-N,N,β-trimethyl-5H-dibenz[b,f]azepine-5-propanamine, 5-(γ-dimethylamino-β-methylpropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine, 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenz[b,f]azepine + [13] |
Target |
Mechanism NET inhibitors(Norepinephrine transporter inhibitors), SERT inhibitors(Serotonin transporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (27 Jan 1965), |
Regulation- |
Molecular FormulaC24H30N2O4 |
InChIKeyYDGHCKHAXOUQOS-BTJKTKAUSA-N |
CAS Registry521-78-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02408 | Trimipramine Maleate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Depressive Disorder | JP | 27 Jan 1965 |